| 10-Q | 2020-03-31 | Filed 2020-05-15 |
| 10-K | 2019-12-31 | Filed 2020-03-30 |
| S-1 | 2019-10-18 | Public Filing |
| 8-K | 2020-03-23 | Officers |
| 8-K | 2020-01-30 | Officers |
| 8-K | 2019-12-17 | |
| 8-K | 2019-11-19 | |
| 8-K | 2019-11-07 |
| Comps ($ TTM) | Market Cap | Gross Margin | EV/EBITDA | Ret on Assets | Assets | Liabilities | Revenue | G Profit | Net Income | EBITDA | EV |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Link Motion (LKM) | 0 | 0% | 853,628,000,000 | 377,864,000,000 | 0 | 0 | 0 | 0 | -91,397,001,000 | ||
| Dais Analytic (DLYT) | 0 | 36% | 0.0 | -597% | 413,706,000 | 8,699,663,000 | 1,055,259,000 | 377,909,000 | -2,469,890,000 | -2,184,371,000 | -13,775,000 |
| Dominovas Energy (DNRG) | |||||||||||
| Jumia (JMIA) | |||||||||||
| Cerence (CRNC) | |||||||||||
| Visium Technologies (VISM) | 0 | 0.0 | -31,116% | 2,558,000 | 3,140,777,000 | 0 | 0 | -795,949,000 | -795,949,000 | -2,559,000 | |
| Renewable Energy Acquisition (REAC) | 0 | 0.0 | 2,353,600% | 0 | 0 | -23,536,000 | -21,806,000 | -1,000 | |||
| Headhunter Group (HHR) | |||||||||||
| Endonovo Therapeutics (ENDV) | 0 | 73% | -0.8 | -301% | 3,413,615,000 | 19,979,611,000 | 203,851,000 | 149,574,000 | -10,267,853,000 | -9,617,427,000 | 7,447,616,000 |
| InMode (INMD) | |||||||||||
| Rich Pharmaceuticals (RCHA) | 0 | -6% | 0.0 | -4,521% | 37,429,000 | 6,396,089,000 | 115,000,000 | -6,625,000 | -1,692,341,000 | -2,355,974,000 | -6,223,000 |
| Granite Real Estate (GRP) | |||||||||||
| W&E Source (WESC) | 0 | 100% | 0.0 | -419% | 14,314,000 | 182,161,000 | 527,000 | 527,000 | -60,006,000 | -60,006,000 | -2,931,000 |
| Growlife (PHOT) | 0 | 33% | 0.0 | -130% | 4,625,508,000 | 9,063,884,000 | 6,743,804,000 | 2,192,581,000 | -6,029,017,000 | -4,694,925,000 | -201,073,000 |
| Arete Industries (ARET) | |||||||||||
| Juniper Industrial (JIH) | |||||||||||
| Sundial Growers (SNDL) | |||||||||||
| PositiveID Corp (PSID) | |||||||||||
| US Stem Cell (USRM) | 0 | 58% | -0.2 | -481% | 656,240,000 | 9,770,052,000 | 2,763,385,000 | 1,597,926,000 | -3,158,293,000 | -2,255,964,000 | 378,392,000 |
| Fiverr (FVRR) |
| Balance Sheet ($) | ||
| Cash | ||
| Accounts Receivable | ||
| Inventory | ||
| PP&E | ||
| Assets | ||
| Accounts Payable | ||
| Long-Term Debt | ||
| Liabilities | ||
| Stockholders' Equity | ||
| Income Statement ($) | ||
| Revenue | ||
| Cost of Revenue | ||
| Gross Profit | ||
| R&D | ||
| SG&A | ||
| Tax | ||
| Net Income | ||
| Cash Flow ($) | ||
| Cash Operating | ||
| Cash Investing | ||
| Cash Financing | ||